20 May 2013
Keywords: novartis, alnylam, extend, rnai, alliance, through, usa-based
Article | 21 July 2008
USA-based Alnylam Pharmaceuticals says that Swiss drug major Novartis has elected to extend its collaboration with the firm for an ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 July 2008
17 May 2013
© 2013 thepharmaletter.com